As of April 19, 2025, Verrica Pharmaceuticals (VRCA) has a market cap of $45.018 million USD. According to our data, Verrica Pharmaceuticals is ranked No.8140 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $45.02 M |
-28.99%
|
Dec 31, 2024 | $63.40 M |
-90.44%
|
Dec 29, 2023 | $0.66 B |
166.18%
|
Dec 30, 2022 | $0.25 B |
-69.98%
|
Dec 31, 2021 | $0.83 B |
-20.42%
|
Dec 31, 2020 | $1.04 B |
-27.56%
|
Dec 31, 2019 | $1.44 B |
94.97%
|
Dec 31, 2018 | $0.74 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Aclaris Therapeutics
ACRS
|
$0.12 B |
0.000 M
|
![]() USA
|
![]() Journey Medical
DERM
|
$0.14 B |
37.500 M
|
![]() USA
|
![]() Biofrontera
BFRI
|
$7.54 M |
0.000 M
|
![]() USA
|
![]() Sol-Gel Technologies
SLGL
|
$15.32 M |
0.000 M
|
![]() Israel
|
![]() Arcutis Biotherapeutics
ARQT
|
$1.54 B |
0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Evolus
EOLS
|
$0.69 B |
-0.000 M
|
![]() USA
|
![]() Krystal Biotech
KRYS
|
$4.87 B |
0.000 M
|
![]() USA
|
![]() Cutera
CUTR
|
$1.96 M |
1.593 M
|
![]() USA
|
Market Cap | = | VRCA Stock Price | * | VRCA Shares Outstanding |
= | $0.49 | * | 91.78 M | |
= | $45.02 M |